Product Images Fluticasone Propionate

This table presents drug-related adverse events associated with the application of Fluticasone in comparison to Vehicle, analyzed by frequency and severity. The study reported infection, eczema, viral warts, herpes simplex, erythema, burning, stinging, blisters, and dryness of the skin as the possible side effects.*

Table 2 shows the adverse events reported in a pediatric open-label trial with 51 participants using Fluticasone twice daily. The adverse events included burning, dusky erythema, erythematous rash, facial telangiectasial, non-facial telangiectasia, and urticaria. The percentages of participants who experienced these events ranged from 2.0% to 4.9%. Additional details on the adverse events can be found in the accompanying text.*

The table displays the mean improvements over the baseline for clinical signs observed in four different studies comparing Fluticasone Propionate Cream with a vehicle. The clinical signs observed were erythema, thickening, and scaling. The results are shown in numerical values.*

This is a table displaying the physician's assessment of clinical response for Fluticasone Propionate Cream used once or twice daily in two different studies. The table shows the percentage of patients who were cleared, showed excellent, good, fair, poor or worse clinical response in each study.*

This is a table presenting clinical signs and symptoms in two studies with the use of Fluticasone Propionate cream. The table shows mean improvements over baseline for skin conditions such as erythema, pruritus, thickening, lichenification, vesiculation, and crusting. The improvements are compared between Fluticasone Propionate cream used once daily and twice daily in Study 1 and Study 2.*

The text is not readable and appears to contain errors. It is not possible to generate a useful description.*